Harrison [40] identified BNP as a strong predictor of cardiovascular mortality in end-stage renal disease (ESRD) patients, with elevated BNP levels linked to an increased risk of cardiovascular death. This evidence concerns the gene NPPB and stage 5 chronic kidney disease.